The Official pharmaceutical laboratories and their relevance to Brazil’s public health

Authors

  • Jorge Lima de Magalhães Escola de Química da Universidade Federal do Rio de Janeiro - EQ/UFRJ

DOI:

https://doi.org/10.3395/reciis.v5i1.512

Keywords:

official pharmaceutical laboratories, public production of medicines, public health, pharmaceutical industry

Abstract

This paper identifies the current portfolio of the Brazilian Network for the Public Production of Medicines (RBPPM) and evaluates the modernization and expansion of the Official Pharmaceutical Laboratories (OPLs) production capacity in the last seven years. Investments of about R$ 300 million have been made to expand the annual installed capacity from 5 to 16.6 billion Pharmaceutical Units1 (PUs). The work consisted of interviews, literature searches and queries to the database of the Official Laboratories Association, National Health Surveillance Agency (ANVISA), Ministry of Health (MS) and Ministry of Science and Technology (MCT). According to the RBPPM portfolio, 99% are similar drugs and the majority of the registers address hypertension and analgesia treatments. The laboratories structure can be considered national property, not only because they produce drugs neglected by the private industry but also because they serve as price regulators and have the potential to develop new pharmaceutical products and formulations. The leading Official Pharmaceutical Laboratories are skilled and competent both in human resources and infrastructure, causing OPLs to be strategic to the MH, thus contributing to the relevance in healthcare.

Author Biography

Jorge Lima de Magalhães, Escola de Química da Universidade Federal do Rio de Janeiro - EQ/UFRJ

Escola de Química da Universidade Federal do Rio de Janeiro - EQ/UFRJ; Instituto de
Tecnologia em Fármacos da Fundação Oswaldo Cruz - Farmanguinhos/Fiocruz. Rio de Janeiro,
Brasil.

How to Cite

Magalhães, J. L. de. (2011). The Official pharmaceutical laboratories and their relevance to Brazil’s public health. Revista Eletrônica De Comunicação, Informação & Inovação Em Saúde, 5(1). https://doi.org/10.3395/reciis.v5i1.512

Issue

Section

Original articles